Keyphrases
DNA Adducts
100%
DNA Damage
70%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
30%
Canine Cancer
28%
Lung Tumorigenesis
28%
Cancer Patients
28%
Formaldehyde
28%
Chemotherapy Treatment
28%
Cyclophosphamide
28%
Mouse Lung
28%
Doxorubicin
28%
Busulfan
28%
Aristolochic Acid
28%
Rat Liver
28%
Rat Kidney
28%
Untargeted
28%
Doxorubicin Treatments
28%
Alkylating Drugs
19%
Oncogenesis
18%
Renal Cancer
14%
Upper Tract Urothelial Carcinoma
11%
High-resolution Accurate Mass
11%
Chemotherapy
9%
High-resolution
9%
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
9%
Data Dependency
9%
Reactive Species
9%
Neutral Loss
9%
Mass Spectral Analysis
9%
Tobacco Exposure
9%
Lung
9%
Spectral Comparison
9%
Lung Cancer
9%
Cigarette Smokers
9%
Metabolism
9%
Carcinogen
9%
Tobacco Products
9%
Full-scan
9%
Endogenous Levels
9%
Carcinogenic Effects
9%
Scanned Data
9%
Fanconi Anemia
7%
Acrolein
7%
Doxorubicinol
6%
Mechanism of Action
6%
Personalized Chemotherapy
6%
Cancer Chemotherapy
6%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
46%
Chemotherapy
39%
Biological Marker
39%
Busulfan
28%
NNK
28%
A J Mouse
28%
Cyclophosphamide
28%
Aristolochic Acid
28%
Doxorubicin
28%
Carcinogenesis
28%
Transitional Cell Carcinoma
11%
Acrolein
7%
Side Effect
7%
Fanconi Anemia
7%
Cancer Chemotherapy
5%
Carcinogen
5%
Doxorubicinol
5%